What is Cagrilintide?
Cagrilintide is a long-acting synthetic analogue of amylin. Amylin is a peptide hormone co-secreted with insulin by pancreatic beta cells and participates in metabolic and satiety-related signalling.
Why is Cagrilintide discussed with Semaglutide?
Cagrilintide and semaglutide influence different biological systems. Semaglutide activates the GLP-1 receptor, while cagrilintide acts through amylin-related pathways. This has led researchers to investigate the combination known as CagriSema.
Evidence status
Mechanistic evidence is strong and human clinical development is substantial and ongoing. Outcomes belong to the preparations and populations actually studied.